Scilex Holding Company Depreciation
Scilex Holding Company (SCLX) reported Depreciation of $800.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- Scilex Holding Company depreciation for the quarter ending 2026-06-30 was $800.00K, a 39900.00% increase year-over-year.
- Scilex Holding Company depreciation for the quarter ending 2026-03-31 was $800.00K, a 79900.00% increase year-over-year.
- Scilex Holding Company depreciation for the quarter ending 2025-12-31 was $253.90K, a 12595.00% increase year-over-year.
- Scilex Holding Company depreciation for the quarter ending 2025-09-30 was $2.00K, a 50.00% decline year-over-year.
- Scilex Holding Company depreciation for fiscal 2025 was $258.90K, a 1749.29% increase from fiscal 2024.
- Scilex Holding Company depreciation for fiscal 2024 was $14.00K, a 65.00% decline from fiscal 2023.
- Scilex Holding Company depreciation for fiscal 2023 was $40.00K, a 0.00% change from fiscal 2022.
- Scilex Holding Company depreciation for fiscal 2022 was $40.00K, a 2.56% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $800.00K 10-Q · filed 2026-08-14 | $1.60M 10-Q · filed 2026-08-14 | $1.85M derived: sum of 3 quarters · filed 2026-08-14 | $1.86M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $800.00K 10-Q · filed 2026-05-20 | $1.05M derived: sum of 2 quarters · filed 2026-05-20 | $1.06M derived: sum of 3 quarters · filed 2026-05-20 | $1.06M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $253.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $255.90K derived: sum of 2 quarters · filed 2026-04-10 | $257.90K derived: sum of 3 quarters · filed 2026-08-14 | $258.90K 10-K · filed 2026-04-10 | |
| 2025-09-30 | $2.00K 10-Q · filed 2025-11-14 | $4.00K derived: sum of 2 quarters · filed 2026-08-14 | $5.00K 10-Q · filed 2025-11-14 | $7.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $2.00K 10-Q · filed 2026-08-14 | $3.00K 10-Q · filed 2026-08-14 | $5.00K derived: sum of 3 quarters · filed 2026-08-14 | $9.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $1.00K 10-Q · filed 2026-05-20 | $3.00K derived: sum of 2 quarters · filed 2026-05-20 | $7.00K derived: sum of 3 quarters · filed 2026-05-20 | $11.00K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2024-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $6.00K derived: sum of 2 quarters · filed 2026-04-10 | $10.00K derived: sum of 3 quarters · filed 2026-04-10 | $14.00K 10-K · filed 2026-04-10 | |
| 2024-09-30 | $4.00K 10-Q · filed 2025-11-14 | $8.00K derived: sum of 2 quarters · filed 2025-11-14 | $12.00K 10-Q · filed 2025-11-14 | $20.00K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $4.00K 10-Q · filed 2025-08-13 | $8.00K 10-Q · filed 2025-08-13 | $16.00K derived: sum of 3 quarters · filed 2025-08-13 | $28.00K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $4.00K 10-Q · filed 2025-05-14 | $12.00K derived: sum of 2 quarters · filed 2025-05-14 | $24.00K derived: sum of 3 quarters · filed 2025-05-14 | $34.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $20.00K derived: sum of 2 quarters · filed 2025-03-31 | $30.00K derived: sum of 3 quarters · filed 2025-03-31 | $40.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $12.00K 10-Q · filed 2025-01-17 | $22.00K derived: sum of 2 quarters · filed 2025-01-17 | $32.00K 10-Q · filed 2025-01-17 | $42.00K derived: sum of 4 quarters · filed 2025-01-17 | |
| 2023-06-30 | $10.00K 10-Q · filed 2024-08-13 | $20.00K 10-Q · filed 2024-08-13 | $10.00K 10-Q · filed 2023-08-11 | $30.00K derived: sum of 3 quarters · filed 2024-08-13 | $40.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $10.00K 10-Q · filed 2024-05-13 | $20.00K derived: sum of 2 quarters · filed 2024-05-13 | $30.00K derived: sum of 3 quarters · filed 2024-05-13 | $50.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $20.00K derived: sum of 2 quarters · filed 2024-03-12 | $40.00K derived: sum of 3 quarters · filed 2024-03-12 | $40.00K 10-K · filed 2024-03-12 | |
| 2022-09-30 | $10.00K 10-Q · filed 2023-11-14 | $30.00K derived: sum of 2 quarters · filed 2023-11-14 | $30.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $20.00K 10-Q · filed 2023-08-11 | $20.00K 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | $10.00K 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | $39.00K 10-K · filed 2024-03-12 | ||||
| 2020-12-31 | $40.00K 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |